Umenzi ukucoceka okuphezulu kwe-CAS 1197-18-8 Tranexamic Acid
I-Tranexamic acid, ekwabizwa ngokuba yi-tranexamic acid, iphuma kwi-lysine enesakhiwo esifana ne-tyrosine. Iqinisekiswa luvavanyo lweklinikhi, ifanelekile kuzo zonke iintlobo zesikhumba kwaye inokususa umbala, ibe mhlophe, kwaye ikhanyise amabala, anje: ibala emva kokuvezwa lilanga, amabala amnyama (i-chloasma, i-freckles, i-senile lentils, njl.), ulusu olubuthathaka, i-Acne kunye nokuvutha, ukunakekelwa emva kokuhlinzwa emva kwe-laser, unyango lwe-pulsed light, njl. Ngoko ke, i-tranexamic acid inokucetyiswa ukuba isetyenziswe kwizinto zokuthambisa ezifana ne-creams, i-lotions, i-essences, i-lotions, kunye neemaski zobuso.
I-Tranexamic acid sisiyobisi sokwenziwa kwe-amino acid antifibrinolytic esinokukhuphisana ngokunqanda ukubotshwa kwe-lysine kwi-fibrin kwi-plasmin, ngaloo ndlela inqanda i-lysis ye-fibrin clots kunye nokuvelisa i-hemostasis. Isetyenziswa ikakhulu kwiklinikhi. Kwiintlobo ezahlukeneyo zokopha okubangelwa yi-hyperfibrinolysis.
Tranexamic acid Applications
![1197-18-8 FACTORYw5m](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8cfa6c37418417.png)
1. I-Tranexamic acid iyiyeza elichasayo le-fibrinolytic, inokunyanga ukopha okwahlukeneyo kunye nokungapheliyo kunye nokufezekisa i-hemostasis.
I-2.Tranexamic acid inokunciphisa ukuveliswa kwe-melanin: Iyakwazi ukukhuphisana ngokuthe ngqo kunye ne-tyrosine kwiiseli, inqanda umphumo we-catalytic we-tyrosine metabolism, kunye nokunciphisa ukuveliswa kwe-melanin.
![I-CAS 1197-18-8txb](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8d06296aa28089.png)
3. Ukuthintela i-angiogenesis: Iyakwazi ukukhuphisana ngokuthe ngqo kunye ne-tyrosine kwiiseli, inqanda umphumo we-catalytic we-tyrosine metabolism, kwaye inqanda i-angiogenesis yesikhumba. Oku kunokunciphisa inani lemithambo yegazi ngaphakathi nakufutshane nezilonda ze-chloasma, ukunciphisa ukwenzeka kokuvela kokukrala, kwaye ngaloo ndlela kunciphise ukubunjwa okuqhubekayo kwe-chloasma.
I-4.Tranexamic acid inokunciphisa ukubonakaliswa kwe-cytokines e-pro-inflammatory kunye ne-chemokines ukwenza i-anti-inflammatory effects, enokuthi ithintele ngokufanelekileyo ukuvela kwe-allergies kunye nokunciphisa ukubunjwa kwe-acne.
![Tranexamic Acidxdg](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8d0fd0dab42839.png)
5. I-Tranexamic acid ine-Anti-aging kunye ne-anti-photoaging properties. Iphucula i-hyaluronic acid synthesis ngokwandisa inani leeseli ze-epidermal, inciphisa ukuthotywa kwe-matrix ye-extracellular kwi-dermis ngokuthintela i-plasmin, kwaye inokunciphisa amanqanaba ezinto ezine-oxidative egazini ukuphucula ukuguga kwendalo kolusu. Iphucula i-UVB-induced photoaging ngokunyusa i-mitochondrial biogenesis, ilawula ukukhuselwa kwehomoni ngokunyusa ukubonakaliswa kwe-estrogen receptors kumphezulu weeseli zemast, kunye nokuphucula ukufota kwe-UVA-induced photoaging.
Tranexamic acid Specification
IHebei WeiBang Biotechnology Co., Ltd
Igama lemveliso | Tranexamic acid | Inombolo yeCAS | 1197-18-8 |
Umhla weMveliso | 2023/12/01 | Umhla weNgxelo | 2023/12/01 |
Ubungakanani | 10,000KG | Umhla woVavanyo | 2023/12/01 |
IBatchNo | WB20231201 | Beka ubomi kwishelufa | iminyaka eyi-2 |
Izinto zoVavanyo | Inkcazo | ||
Imbonakalo | Umgubo wekristale omhlophe | ||
Ukuchongwa | KUNYE | ||
Ilahleko ekomisweni | ≤0.50% | ||
pH | 7.0-8.0 | ||
Isivavanyi | ≥99.0 | ||
Uthuthu olune-sulphated | ≤0.10% | ||
Into enxulumeneyo | Ukungcola A: ≤0.10% | ||
Ukungcola B: ≤0.20% | |||
Nakuphi na okunye ukungcola: ≤0.10% | |||
Konke okunye ukungcola: ≤0.20% | |||
Iikloridi | ≤140ppm | ||
Ubalo lweepleyiti lulonke | ≤1000cfu/g | ||
Igwele kunye nokungunda | ≤100cfu/g | ||
Pb | ≤10mg/kg | ||
Njengoko | ≤2mg/kg | ||
Hg | ≤1mg/kg | ||
Cd | ≤5mg/kg | ||
Ukuqukumbela | Ufanelekile |